

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | 1 | — | — | — | 2 |
| Ischemic stroke | D000083242 | — | — | — | 1 | — | — | — | 1 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | — | 1 |
| Middle cerebral artery infarction | D020244 | EFO_1001045 | G46.0 | — | 1 | — | — | — | 1 |
| Posterior cerebral artery infarction | D020762 | EFO_1001118 | G46.2 | — | 1 | — | — | — | 1 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | 1 | — | — | — | — | 1 |
| Pulmonary sarcoidosis | D017565 | DOID_13406 | D86.0 | 1 | — | — | — | — | 1 |
| Drug common name | CENPLACEL-L |
| INN | cenplacel |
| Description | Cenplacel-l is a cell pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Cell |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2107867 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | OOH12XV6XR (ChemIDplus, GSRS) |
